| pubmed-article:9751403 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9751403 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:9751403 | lifeskim:mentions | umls-concept:C0025936 | lld:lifeskim |
| pubmed-article:9751403 | lifeskim:mentions | umls-concept:C0205127 | lld:lifeskim |
| pubmed-article:9751403 | lifeskim:mentions | umls-concept:C1947901 | lld:lifeskim |
| pubmed-article:9751403 | lifeskim:mentions | umls-concept:C0086027 | lld:lifeskim |
| pubmed-article:9751403 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:9751403 | pubmed:dateCreated | 1998-10-19 | lld:pubmed |
| pubmed-article:9751403 | pubmed:abstractText | Human prostate cancer is variably lethal, shows heterogeneous progression, and exhibits a spectrum of histopathology. Traditional rodent models of prostate cancer lack these characteristics. An alternative, autochthonous model of prostate cancer consists of transgenic mice which develop prostate cancer due to prostatic expression of SV40 T antigen. Lethal progression of such cancers in individual mice has not been previously characterized. Studies were undertaken to characterize the longitudinal progression of prostate cancers in these transgenic mice. | lld:pubmed |
| pubmed-article:9751403 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9751403 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9751403 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9751403 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9751403 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9751403 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9751403 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:9751403 | pubmed:issn | 0022-5347 | lld:pubmed |
| pubmed-article:9751403 | pubmed:author | pubmed-author:RossB DBD | lld:pubmed |
| pubmed-article:9751403 | pubmed:author | pubmed-author:ChrispC ECE | lld:pubmed |
| pubmed-article:9751403 | pubmed:author | pubmed-author:GreenbergN... | lld:pubmed |
| pubmed-article:9751403 | pubmed:author | pubmed-author:PientaK JKJ | lld:pubmed |
| pubmed-article:9751403 | pubmed:author | pubmed-author:SandaM GMG | lld:pubmed |
| pubmed-article:9751403 | pubmed:author | pubmed-author:ZengZZ | lld:pubmed |
| pubmed-article:9751403 | pubmed:author | pubmed-author:CharlesL GLG | lld:pubmed |
| pubmed-article:9751403 | pubmed:author | pubmed-author:HsuC XCX | lld:pubmed |
| pubmed-article:9751403 | pubmed:author | pubmed-author:DerrowS ZSZ | lld:pubmed |
| pubmed-article:9751403 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9751403 | pubmed:volume | 160 | lld:pubmed |
| pubmed-article:9751403 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9751403 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9751403 | pubmed:pagination | 1500-5 | lld:pubmed |
| pubmed-article:9751403 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:9751403 | pubmed:meshHeading | pubmed-meshheading:9751403-... | lld:pubmed |
| pubmed-article:9751403 | pubmed:meshHeading | pubmed-meshheading:9751403-... | lld:pubmed |
| pubmed-article:9751403 | pubmed:meshHeading | pubmed-meshheading:9751403-... | lld:pubmed |
| pubmed-article:9751403 | pubmed:meshHeading | pubmed-meshheading:9751403-... | lld:pubmed |
| pubmed-article:9751403 | pubmed:meshHeading | pubmed-meshheading:9751403-... | lld:pubmed |
| pubmed-article:9751403 | pubmed:meshHeading | pubmed-meshheading:9751403-... | lld:pubmed |
| pubmed-article:9751403 | pubmed:meshHeading | pubmed-meshheading:9751403-... | lld:pubmed |
| pubmed-article:9751403 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9751403 | pubmed:articleTitle | Longitudinal cohort analysis of lethal prostate cancer progression in transgenic mice. | lld:pubmed |
| pubmed-article:9751403 | pubmed:affiliation | Department of Surgery/Urology, University of Michigan School of Medicine, Ann Arbor Veterans Administration Medical Center, USA. | lld:pubmed |
| pubmed-article:9751403 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9751403 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:9751403 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9751403 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9751403 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9751403 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9751403 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9751403 | lld:pubmed |
